Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI

SIMPLE SUMMARY: No comprehensive and simple prognostic model based on pretreatment factors exists for patients with epidermal growth factor receptor mutation-positive (EGFRm+) non-small cell lung cancer (NSCLC) undergoing EGFR-tyrosine kinase inhibitors (EGFR-TKIs). A total of 11 independent prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, John Wen-Cheng, Huang, Chen-Yang, Fang, Yueh-Fu, Chang, Ching-Fu, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Wu, Chiao-En
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870328/
https://www.ncbi.nlm.nih.gov/pubmed/35205720
http://dx.doi.org/10.3390/cancers14040977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870328/
https://www.ncbi.nlm.nih.gov/pubmed/35205720
http://dx.doi.org/10.3390/cancers14040977

Ejemplares similares